Home > Insider Trading > Filing (0001209191-22-009249)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1789815	Ourania Tatsis	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Chief Reg. & Quality Off.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2022-02-10	1,230	$237.74	58,027	No	4	F	Direct
Common Stock	Disposition	2022-02-11	100	$233.92	57,927	No	4	S	Direct
Common Stock	Disposition	2022-02-11	78	$234.93	57,849	No	4	S	Direct
Common Stock	Disposition	2022-02-11	70	$235.87	57,779	No	4	S	Direct
Common Stock	Disposition	2022-02-11	42	$236.85	57,737	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $233.92 (range $233.26 to $234.24).
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $234.93 (range $234.28 to $235.25).
Open market sales reported on this line occurred at a weighted average price of $235.87 (range $235.41 to $236.08).
Open market sales reported on this line occurred at a weighted average price of $236.85 (range $236.84 to $236.87).